Clinical Trial Update: A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on AZD7789 evaluating safety and efficacy in participants with advanced or metastatic solid cancers in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• AZD7789

Snippet

Sponsor: AstraZeneca | Conditions: Carcinoma, Non-Small-Cell Lung, Gastric Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING